Mosconi L - Search Results

1

Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Mosconi L, Pupi A, De Leon MJ. Mosconi L, et al. Ann N Y Acad Sci. 2008 Dec;1147:180-95. doi: 10.1196/annals.1427.007. Ann N Y Acad Sci. 2008. PMID: 19076441 Free PMC article. Review.

2

Brain metabolic differences between sporadic and familial Alzheimer's disease.

Mosconi L, Sorbi S, Nacmias B, De Cristofaro MT, Fayyaz M, Cellini E, Bagnoli S, Bracco L, Herholz K, Pupi A. Mosconi L, et al. Neurology. 2003 Oct 28;61(8):1138-40. doi: 10.1212/01.wnl.0000086816.30011.75. Neurology. 2003. PMID: 14581683

3

Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.

Mosconi L, Nacmias B, Sorbi S, De Cristofaro MT, Fayazz M, Tedde A, Bracco L, Herholz K, Pupi A. Mosconi L, et al. J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):370-6. doi: 10.1136/jnnp.2003.014993. J Neurol Neurosurg Psychiatry. 2004. PMID: 14966149 Free PMC article.

4

Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease.

Mosconi L, Pupi A, De Cristofaro MT, Fayyaz M, Sorbi S, Herholz K. Mosconi L, et al. J Nucl Med. 2004 Mar;45(3):382-92. J Nucl Med. 2004. PMID: 15001677 Free article. Clinical Trial.

5

Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study.

Mosconi L, Sorbi S, Nacmias B, De Cristofaro MT, Fayyaz M, Bracco L, Herholz K, Pupi A. Mosconi L, et al. Psychiatry Res. 2004 Feb 15;130(2):141-51. doi: 10.1016/j.pscychresns.2003.12.005. Psychiatry Res. 2004. PMID: 15033184

6

Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.

Mosconi L, Herholz K, Prohovnik I, Nacmias B, De Cristofaro MT, Fayyaz M, Bracco L, Sorbi S, Pupi A. Mosconi L, et al. J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):15-23. doi: 10.1136/jnnp.2003.030882. J Neurol Neurosurg Psychiatry. 2005. PMID: 15607989 Free PMC article.

7

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, Salmon E, Baron JC, De Cristofaro MT, Padovani A, Borroni B, Franceschi M, Bracco L, Pupi A. Mosconi L, et al. Neurology. 2004 Dec 28;63(12):2332-40. doi: 10.1212/01.wnl.0000147469.18313.3b. Neurology. 2004. PMID: 15623696

8

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Mosconi L. Mosconi L. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):486-510. doi: 10.1007/s00259-005-1762-7. Eur J Nucl Med Mol Imaging. 2005. PMID: 15747152 Review.

9

Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.

Mosconi L, De Santi S, Rusinek H, Convit A, de Leon MJ. Mosconi L, et al. Expert Rev Neurother. 2004 Sep;4(5):831-49. doi: 10.1586/14737175.4.5.831. Expert Rev Neurother. 2004. PMID: 15853510 Review.

10

Toward the validation of functional neuroimaging as a potential biomarker for Alzheimer's disease: implications for drug development.

Pupi A, Mosconi L, Nobili FM, Sorbi S. Pupi A, et al. Among authors: mosconi l. Mol Imaging Biol. 2005 Jan-Feb;7(1):59-68. doi: 10.1007/s11307-005-0953-8. Mol Imaging Biol. 2005. PMID: 15912277 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters